306 related articles for article (PubMed ID: 19932748)
1. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1.
Tan AS; Berridge MV
Free Radic Biol Med; 2010 Feb; 48(3):421-9. PubMed ID: 19932748
[TBL] [Abstract][Full Text] [Related]
2. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
Qiu XB; Cadenas E
Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of redox-cycling and arylating quinones on trans-plasma membrane electron transport.
Tan AS; Berridge MV
Biofactors; 2008; 34(3):183-90. PubMed ID: 19734119
[TBL] [Abstract][Full Text] [Related]
4. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.
Siegel D; Gustafson DL; Dehn DL; Han JY; Boonchoong P; Berliner LJ; Ross D
Mol Pharmacol; 2004 May; 65(5):1238-47. PubMed ID: 15102952
[TBL] [Abstract][Full Text] [Related]
5. Dicoumarol impairs mitochondrial electron transport and pyrimidine biosynthesis in human myeloid leukemia HL-60 cells.
González-Aragón D; Ariza J; Villalba JM
Biochem Pharmacol; 2007 Feb; 73(3):427-39. PubMed ID: 17123468
[TBL] [Abstract][Full Text] [Related]
6. Role of NADPH cytochrome P450 reductase in activation of RH1.
Begleiter A; Leith MK; Patel D; Hasinoff BB
Cancer Chemother Pharmacol; 2007 Oct; 60(5):713-23. PubMed ID: 17256129
[TBL] [Abstract][Full Text] [Related]
7. Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism.
Cullen JJ; Hinkhouse MM; Grady M; Gaut AW; Liu J; Zhang YP; Weydert CJ; Domann FE; Oberley LW
Cancer Res; 2003 Sep; 63(17):5513-20. PubMed ID: 14500388
[TBL] [Abstract][Full Text] [Related]
8. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
Han Y; Shen H; Carr BI; Wipf P; Lazo JS; Pan SS
J Pharmacol Exp Ther; 2004 Apr; 309(1):64-70. PubMed ID: 14718602
[TBL] [Abstract][Full Text] [Related]
9. Iron deficiency aggravates DMNQ-induced cytotoxicity via redox cycling in kidney-derived cells.
Yoshihara D; Fujiwara N; Eguchi H; Sakiyama H; Suzuki K
Free Radic Res; 2022; 56(7-8):544-554. PubMed ID: 36469660
[TBL] [Abstract][Full Text] [Related]
10. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
11. Role of NAD(P)H:quinone oxidoreductase (NQO1) in apoptosis induction by aziridinylbenzoquinones RH1 and MeDZQ.
Nemeikaite-Ceniene A; Dringeliene A; Sarlauskas J; Cenas N
Acta Biochim Pol; 2005; 52(4):937-41. PubMed ID: 15940348
[TBL] [Abstract][Full Text] [Related]
12. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
[TBL] [Abstract][Full Text] [Related]
13. The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger.
Zhu H; Jia Z; Mahaney JE; Ross D; Misra HP; Trush MA; Li Y
Cardiovasc Toxicol; 2007; 7(3):202-11. PubMed ID: 17901563
[TBL] [Abstract][Full Text] [Related]
14. Cellular density and cell type are the key factors in growth inhibition induced by 2,5bis [1-aziridinyl]-1,4 benzoquinone (DZQ).
Córdoba-Pedregosa Mdel C; Villalba JM; González-Aragón D; Bello RI; Alcaín FJ
Anticancer Res; 2006; 26(5A):3535-40. PubMed ID: 17094478
[TBL] [Abstract][Full Text] [Related]
15. Biochemical, cytotoxic, and genotoxic effects of ES936, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, in cellular systems.
Dehn DL; Siegel D; Swann E; Moody CJ; Ross D
Mol Pharmacol; 2003 Sep; 64(3):714-20. PubMed ID: 12920209
[TBL] [Abstract][Full Text] [Related]
16. Autoxidation of extracellular hydroquinones is a causative event for the cytotoxicity of menadione and DMNQ in A549-S cells.
Watanabe N; Forman HJ
Arch Biochem Biophys; 2003 Mar; 411(1):145-57. PubMed ID: 12590933
[TBL] [Abstract][Full Text] [Related]
17. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
18. Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase.
Siemankowski LM; Morreale J; Butts BD; Briehl MM
Cancer Res; 2000 Jul; 60(13):3638-44. PubMed ID: 10910079
[TBL] [Abstract][Full Text] [Related]
19. Plasma membrane electron transport in pancreatic β-cells is mediated in part by NQO1.
Gray JP; Eisen T; Cline GW; Smith PJ; Heart E
Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E113-21. PubMed ID: 21505151
[TBL] [Abstract][Full Text] [Related]
20. Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
Colucci MA; Moody CJ; Couch GD
Org Biomol Chem; 2008 Feb; 6(4):637-56. PubMed ID: 18264564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
